Skip to main content
Development of a new bio-printer and bio-ink using Structo MSLA 3D Printer

Industry Sector

Biomedical

Objective

  • To develop a novel MSLA based bio printer and bio ink.

  • Open up new potential commercial opportunity for industry collaborator e.g. in-vitro skin model and testing.

Innovation Applied

  • Develop a novel 3D bio-printer based on MSLA technology [process innovation].

  • Optimised and compatible bio-ink development [material innovation].

Key Benefits

  • Develop the world first (Singapore-based) 3D bio printing system based on MSLA technology (easy to scale up, free of nozzle clogging, high resolution, high speed printing, etc.)

Collaborators

Images

  • STORY1